IMRX Immuneering Corp
Nasdaq · SEC CIK 1790340 · EDGAR
- Bought, last 12 months
- $423.1K 13 purchases by 8 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 143 since 2021-07-30, latest 2026-07-17 16:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Feinberg Peter | Dir | $225.7K | — |
| Schall Thomas J. | Dir | $101.1K | — |
| Hall Brett Matthew | CSO | $35.5K | — |
| Brakewood Harold Eugene | Chief Business Off | $25.0K | — |
| Neufeld Leah R | CHRO | $16.0K | — |
| Zeskind Benjamin J. | Pres AND CEO, Dir | $10.9K | — |
| Bookman Michael | CLO, Sec | $6,967 | — |
| Morales Mallory | CAO | $1,917 | — |
Transactions 77
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-24 16:11 | 2026-06-23 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir | P - Purchase | $4.56 | +2,400 | 2.32M | +0.1% | +$10.9K | |
| 2026-06-16 16:15 | 2026-06-15 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $4.15 | +6,035 | 382.5K | +2% | +$25.0K | |
| 2026-03-17 | 2026-03-13 | IMRX | Neufeld Leah R | CHRO | A - Grant | $4.29 | +3,628 | 29.6K | +14% | +$15.6K | |
| 2026-01-21 | 2026-01-16 | IMRX | Brakewood Harold Eugene | Chief Business Off | P - Purchase | $4.76 | +5,250 | 11.1K | +91% | +$25.0K | |
| 2026-01-20 | 2026-01-15 | IMRX | Schall Thomas J. | Dir | P - Purchase | $4.67 | +21.6K | 74.5K | +41% | +$101.1K | |
| 2026-01-16 | 2026-01-15 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $4.57 | +2,298 | 376.5K | +0.6% | +$10.5K | |
| 2026-01-15 | 2026-01-13 | IMRX | Neufeld Leah R | CHRO | P - Purchase | $4.15 | +2,626 | 26.0K | +11% | +$10.9K | |
| I | 2026-01-14 | 2026-01-12 | IMRX | Feinberg Peter | Dir | P - Purchase | $4.35 | +20.0K | 135.4K | +17% | +$87.0K |
| 2025-10-07 | 2025-10-03 | IMRX | Feinberg Peter | Dir | P - Purchase | $6.67 | +7,500 | 156.8K | +5% | +$50.0K | |
| 2025-10-02 | 2025-10-01 | IMRX | Bookman Michael | CLO, Sec | P - Purchase | $6.83 | +1,020 | 4,870 | +26% | +$6,967 | |
| 2025-10-02 | 2025-10-01 | IMRX | Morales Mallory | CAO | P - Purchase | $6.39 | +300 | 27.5K | +1% | +$1,917 | |
| 2025-10-02 | 2025-10-01 | IMRX | Neufeld Leah R | CHRO | P - Purchase | $6.38 | +800 | 23.3K | +4% | +$5,104 | |
| 2025-10-01 | 2025-09-30 | IMRX | Feinberg Peter | Dir | P - Purchase | $7.03 | +7,500 | 149.3K | +5% | +$52.7K | |
| 2025-09-30 | 2025-09-29 | IMRX | Feinberg Peter | Dir | P - Purchase | $7.18 | +5,000 | 141.8K | +4% | +$35.9K | |
| 2025-09-17 | 2025-09-15 | IMRX | Neufeld Leah R | CHRO | A - Grant | $1.43 | +11.8K | 22.5K | +110% | +$16.9K | |
| 2025-09-17 | 2025-09-15 | IMRX | Morales Mallory | CAO | A - Grant | $1.43 | +14.5K | 27.2K | +114% | +$20.7K | |
| 2025-09-17 | 2025-09-15 | IMRX | Hall Brett Matthew | CSO | A - Grant | $1.43 | +14.9K | 374.2K | +4% | +$21.3K | |
| 2025-07-07 | 2025-07-02 | IMRX | HAUSMAN DIANA | Dir | P - Purchase | $3.60 | +2,500 | 2,500 | New | +$9,000 | |
| I | 2025-07-07 | 2025-07-02 | IMRX | HAUSMAN DIANA | Dir | P - Purchase | $3.62 | +3,000 | 3,000 | New | +$10.9K |
| 2025-07-07 | 2025-07-02 | IMRX | Neufeld Leah R | CHRO | P - Purchase | $3.57 | +700 | 10.7K | +7% | +$2,499 | |
| M | 2025-07-03 | 2025-07-01+ | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $3.49 | +10.0K | 2.31M | +0.4% | +$34.9K |
| 2025-06-30 | 2025-06-27 | IMRX | Schall Thomas J. | Dir | P - Purchase | $3.66 | +9,500 | 52.9K | +22% | +$34.8K | |
| 2025-06-24 | 2025-06-20 | IMRX | Brakewood Harold Eugene | Chief Business Off | P - Purchase | $2.53 | +1,900 | 5,800 | +49% | +$4,807 | |
| M | 2025-06-24 | 2025-06-20+ | IMRX | Hall Brett Matthew | CSO | P - Purchase | $2.58 | +13.4K | 359.3K | +4% | +$34.6K |
| 2025-06-23 | 2025-06-18 | IMRX | Feinberg Peter | Dir | P - Purchase | $2.53 | +25.0K | 136.8K | +22% | +$63.2K | |
| 2025-06-20 | 2025-06-18 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $2.39 | +21.0K | 2.30M | +0.9% | +$50.2K | |
| 2025-06-18 | 2025-06-17 | IMRX | Schall Thomas J. | Dir | P - Purchase | $2.21 | +40.5K | 43.4K | +1,396% | +$89.5K | |
| 2024-09-17 | 2024-09-15 | IMRX | Morales Mallory | CAO | A - Grant | $1.62 | +4,458 | 12.7K | +54% | +$7,222 | |
| MI | 2024-04-03 | 2024-04-01 | IMRX | Cormorant Private Healthcare Fund III LP | 10% | S - Sale | $2.90 | -400.0K | 3.29M | -11% | -$1.16M |
| M | 2024-03-25 | 2024-03-21+ | IMRX | Morales Mallory | CAO | P - Purchase | $2.68 | +1,500 | 7,885 | +23% | +$4,013 |
| 2024-03-25 | 2024-03-15 | IMRX | Morales Mallory | CAO | A - Grant | $1.62 | +4,344 | 6,778 | +178% | +$7,037 | |
| 2024-03-25 | 2024-03-22 | IMRX | Brakewood Harold Eugene | Chief Business Off | P - Purchase | $2.57 | +3,900 | 3,900 | New | +$10.0K | |
| 2024-03-25 | 2024-03-22 | IMRX | Schall Thomas J. | Dir | P - Purchase | $2.55 | +2,900 | 2,900 | New | +$7,395 | |
| 2024-03-25 | 2024-03-22 | IMRX | Feinberg Peter | Dir | P - Purchase | $2.55 | +25.0K | 111.8K | +29% | +$63.7K | |
| 2024-03-21 | 2024-03-15 | IMRX | Neufeld Leah R | CHRO | A - Grant | $1.62 | +6,211 | 6,211 | New | +$10.1K | |
| 2024-03-21 | 2024-03-20 | IMRX | Neufeld Leah R | CHRO | P - Purchase | $2.88 | +3,818 | 10.0K | +61% | +$11.0K | |
| 2024-03-21 | 2024-03-15 | IMRX | Hall Brett Matthew | CSO | A - Grant | $1.62 | +6,211 | 338.9K | +2% | +$10.1K | |
| 2024-03-21 | 2024-03-20 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $2.86 | +7,000 | 345.9K | +2% | +$20.0K | |
| 2024-03-19 | 2024-03-18 | IMRX | BERMAN ANN E | Dir | P - Purchase | $2.13 | +58.0K | 67.5K | +610% | +$123.5K | |
| 2024-03-19 | 2024-03-19 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $2.77 | +20.0K | 2.28M | +0.9% | +$55.4K | |
| M | 2024-03-19 | 2024-03-18+ | IMRX | Feinberg Peter | Dir | P - Purchase | $2.44 | +75.0K | 56.8K | New | +$183.2K |
| 2024-03-19 | 2024-03-15 | IMRX | Bookman Michael | CLO, Sec | A - Grant | $1.62 | +1,448 | 3,850 | +60% | +$2,346 | |
| MI | 2024-03-18 | 2024-03-14+ | IMRX | Cormorant Global Healthcare Master Fund, LP | 10% | S - Sale | $3.03 | -909.1K | 3.86M | -19% | -$2.75M |
| D | 2022-12-27 | 2022-12-22 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,500 | 2.26M | +0.1% | +$7,525 |
| 2022-05-27 | 2022-05-25 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $3.92 | +2,551 | 332.7K | +0.8% | +$10,000 | |
| 2022-05-18 | 2022-05-17 | IMRX | Bookman Michael | GC AND Sec | P - Purchase | $4.88 | +1,000 | 2,402 | +71% | +$4,880 | |
| 2022-05-17 | 2022-05-16 | IMRX | KEATING LAURIE | Dir | P - Purchase | $5.00 | +7,000 | 14.0K | +100% | +$35.0K | |
| 2022-05-12 | 2022-05-12 | IMRX | Amin Biren | CFO, Treas | P - Purchase | $4.42 | +1,000 | 7,898 | +14% | +$4,420 | |
| D | 2022-04-14 | 2022-04-12 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,000 | 2.26M | +0.1% | +$6,020 |
| 2022-03-24 | 2022-03-23 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $8.02 | +3,000 | 2.26M | +0.1% | +$24.1K | |
| 2022-03-23 | 2022-03-23 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $7.91 | +1,050 | 330.1K | +0.3% | +$8,306 | |
| 2022-03-22 | 2022-03-22 | IMRX | Barrett Scott | Chief MEDICAL Off | P - Purchase | $7.49 | +900 | 7,563 | +14% | +$6,741 | |
| 2022-03-16 | 2022-03-15 | IMRX | Feinberg Peter | Dir | P - Purchase | $6.75 | +6,667 | 11.8K | +131% | +$45.0K | |
| 2022-03-15 | 2022-03-15 | IMRX | BERMAN ANN E | Dir | P - Purchase | $6.40 | +6,000 | 9,500 | +171% | +$38.4K | |
| D | 2022-03-01 | 2022-02-28 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,000 | 2.25M | +0.1% | +$6,020 |
| 2021-12-22 | 2021-12-22 | IMRX | Hall Brett Matthew | CSO | A - Grant | — | +322.7K | 329.1K | +5,048% | — | |
| 2021-09-21 | 2021-09-20 | IMRX | Feinberg Peter | Dir | P - Purchase | $24.45 | +4,750 | 5,099 | +1,361% | +$116.1K | |
| 2021-09-15 | 2021-09-13 | IMRX | Feinberg Peter | Dir | P - Purchase | $21.25 | +349 | 349 | New | +$7,416 | |
| I | 2021-09-15 | 2021-09-13 | IMRX | Feinberg Peter | Dir | P - Purchase | $21.51 | +5,750 | 392.2K | +1% | +$123.7K |
| 2021-09-14 | 2021-09-13 | IMRX | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $22.87 | +2,083 | 2.60M | +0.1% | +$47.6K | |
| DI | 2021-08-05 | 2021-08-03 | IMRX | Cormorant Asset Management, LP | Former 10% Owner | C - Cnv Deriv | — | +1.70M | 1.70M | New | — |
| DI | 2021-08-05 | 2021-08-03 | IMRX | Cormorant Asset Management, LP | Former 10% Owner | P - Purchase | $15.00 | +550.0K | 2.25M | +32% | +$8.25M |
| D | 2021-08-04 | 2021-08-03 | IMRX | Amin Biren | CFO, Treas | P - Purchase | $15.00 | +4,175 | 6,898 | +153% | +$62.6K |
| D | 2021-08-04 | 2021-08-03 | IMRX | Amin Biren | CFO, Treas | C - Cnv Deriv | — | +2,723 | 2,723 | New | — |
| D | 2021-08-04 | 2021-08-03 | IMRX | Barrett Scott | Chief Medical Off | P - Purchase | $15.00 | +667 | 6,663 | +11% | +$10.0K |
| D | 2021-08-04 | 2021-08-03 | IMRX | Barrett Scott | Chief Medical Off | C - Cnv Deriv | — | +5,996 | 5,996 | New | — |
| 2021-08-04 | 2021-08-03 | IMRX | BERMAN ANN E | Dir | P - Purchase | $15.00 | +3,500 | 3,500 | New | +$52.5K | |
| 2021-08-04 | 2021-08-03 | IMRX | Bookman Michael | GC, Sec | P - Purchase | $15.00 | +1,402 | 1,402 | New | +$21.0K | |
| D | 2021-08-04 | 2021-08-03 | IMRX | CARPENTER ROBERT J | Dir | C - Cnv Deriv | — | +217.2K | 823.8K | +36% | — |
| D | 2021-08-04 | 2021-08-03 | IMRX | CARPENTER ROBERT J | Dir | P - Purchase | $15.00 | +325.0K | 1.15M | +39% | +$4.88M |
| D | 2021-08-04 | 2021-08-03 | IMRX | Hall Brett Matthew | CSO | P - Purchase | $15.00 | +1,353 | 6,393 | +27% | +$20.3K |
| D | 2021-08-04 | 2021-08-03 | IMRX | Hall Brett Matthew | CSO | C - Cnv Deriv | — | +5,040 | 5,040 | New | — |
| 2021-08-04 | 2021-08-03 | IMRX | KEATING LAURIE | Dir | P - Purchase | $15.00 | +7,000 | 7,000 | New | +$105.0K | |
| D | 2021-08-04 | 2021-08-03 | IMRX | Zeskind Benjamin J. | Pres, CEO, Dir, 10% | C - Cnv Deriv | — | +49.1K | 2.60M | +2% | — |
| D | 2021-08-04 | 2021-08-03 | IMRX | Zeskind Benjamin J. | Pres, CEO, Dir, 10% | P - Purchase | $15.00 | +2,098 | 2.60M | +0.1% | +$31.5K |
| DMI | 2021-08-04 | 2021-08-03 | IMRX | Feinberg Peter | Dir | C - Cnv Deriv | — | +338.8K | 257.3K | New | — |
| DMI | 2021-08-04 | 2021-08-03 | IMRX | Feinberg Peter | Dir | P - Purchase | $15.00 | +291.7K | 115.4K | New | +$4.38M |
Purchase Sale Sale after option exercise All abbreviations